Last updated on February 2018

Fatty Liver Disease Collaborative Research in China


Brief description of study

A multi-center, prospective cohort study on the natural history of fatty liver disease in China

Detailed Study Description

This is a multicenter, prospective and open-enrollment epidemiologic study. All the patients with liver biopsy-proven macrovesicular steatosis (>5%) will be enrolled in the baseline cross-sectional analysis. Those who are either diagnosed as NAFLD or ALD, if meeting all the inclusion and exclusion criteria, will be enrolled in the following cohort study, will be followed up after 1 year, 3 years and 5 years with a visit window of +1 month.

Clinical Study Identifier: NCT02391168

Contact Investigators or Research Sites near you

Start Over

Fangping He, MD

The First Affiliated Hospital of Xinjiang Medical University
Urumqi, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.